Reserch progresses in effect of traditional Chinese medicines on cytochrome P450 activities from 2000-2011

Zhongguo Zhongyao Zazhi

Volumn 37, Issue 7, 2012, Pages 871-877

  Yang, Xinbao ^a,b   Liu, Jianxun ^a,b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b XIYUAN HOSPITAL   (China)

Author keywords

Cytochrome P450; Drugs metabolism; Traditional Chinese medicines

Indexed keywords

CYTOCHROME P450;

CHINESE MEDICINE; DRUG INTERACTION; DRUG SAFETY; DRUG TRANSFORMATION; REVIEW;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL;

EID: 84862745729     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20120701     Document Type: Review

References (64)

1. Zhou S F, Koh H L, Gao Y H, et al. Herbal bioactivation: the good, the bad and the ugly[J]. Life Sci, 2004, 74:935.
2. Shimada T, Yamazaki H, Mimura, et at, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians [J]. J Pharmacol Exp Ther, 1994, 270:414.
3. Kolars J C, Lown K S, Schmiedlin-Ren P, et al. CYP3A gene expression in human gut epithelium [J]. Pharmacogenetics, 1994, 4:247.
4. Guengerich F P. Cytochrome P450 3A4: regulation and role in drug metabolism[J]. Annu Rev Pharmacol Toxicol, 1999, 39:1.
5. de Wildt S N, Kearns G L, Leeder J S, et al. Cytochrome P450 3A: ontogeny and drug disposition [J]. Clin Pharmacokinet, 1999, 37:485.
6. Tassaneeyakul W, Guo L Q, Fukuda K, et al. Inhibition selectivity of grape fruit juice components on human cytochromes P450[J]. Arch Biochem Biophys, 2000, 378(2):356.
7. Kimura Y, Ito H, Ohnishi R, et al. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity [J]. Food Chem Toxicol, 2010, 48:429.
8. Wen Y H, Sahi J, Urda E, et al. Effects of bergamottin on human and monkey drug-metabolizing enzymes in primary cultured hepatocytes [J]. Drug Metab Dispos, 2002, 30(9):977.
9. Takeuchi H, Saoo K, Yokohira M, et al. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice [J]. Cancer Res, 2003, 63(22):7581.
10. Yano J K, Hsu M H, Griffin K J, et al. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen[J]. Nat Struct Mol Biol, 2005, 12(9):822.
11. Chan H Y, Leung L K. A potential protective mechanism of soya isoflavones against 7,12-dimethylbenz [a]anthracene tumour initiation[J]. Br J Nutr, 2003, 90(2):457.
12. Henderson M C, Miranda C L, Stevens J F, et al. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, humulus lupulus[J]. Xenobiotica, 2000, 30(3):235.
13. Schwarz D, Kisselev P, Roots I. CYP1A1 genotype-selective inhibition of benzo [a] pyrene activation by quercetin [J]. Eur J Cancer, 2005, 41:151.
14. Doostdar H, Burke M D, Mayer R T. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1 [J]. Toxicol, 2000, 144(1/3):31.
15. Walle T, Walle U K. Novel methoxylated flavone inhibitors of cytochrome P450 1B1 in SCC-9 human oral cancer cells [J]. J Pharm Pharmacol, 2007, 59(6):857.
16. Wen X, Walle U K, Walle T. 5,7-Dimethoxyflavone down regulates CYP1A1 expression and benzo [a] pyrene-induced DNA binding in HepG2 cells[J]. Carcinogenesis, 2005, 26(4):803.
17. Ho P C, Saville D J, Wanwimolruk S. Inhibition of human CYP3A4 activity by grape fruit flavonoids, furanocoumarins and related compounds[J]. J Pharm Pharm Sci, 2001, 4(3):217.
18. Breinholt V M, Rasmussen S E, Brsen K, et al. In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s[J]. Pharmacol Toxicol, 2003, 93(1):14.
19. Backman J T, Menp J, Belle D J, et al. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation [J]. Clin Pharmacol Ther, 2000, 67(4):382.
20. Pouget C, Fagnere C, Basly J P, et al. Synthesis and aromatase inhibitory activity of flavanones [J]. Pharm Res, 2002, 19(3):286.
21. Ta N, Walle T. Aromatase inhibition by bioavailable methylated flavones [J]. J Steroid Biochem Mol Biol, 2007, 107(1/2): 127.
22. Androutsopoulos V P, Papakyriakou A, Vourloumis D, et al. Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes [J]. Pharmacol Ther, 2010, 126:9.
23. Simanek V, Walterova D, Vicar J, et al. Silymarin-an extract from the milk thistle (Silybum marianum) -is it a drug or nutritional supplement? [J]. Ceska Slov Farm, 2001, 50(2):66.
24. Zuber R, Modriansk M, Dvork Z, et al. Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities [J]. Phytother Res, 2002, 16(7):632.
25. Chang T K, Lee W B, Ko H H. Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogenactivating human cytochrome P450 1B1 [J]. Can J Physiol Pharmacol, 2000, 78:874.
26. Chun Y J, Ryu S Y, Jeong T C, et al. Mechanism based inhibition of human cytochrome P450 1A1 by rhapontigenin [J]. Drug Metab Dispos, 2001, 29:389.
27. Lee S K, Kim N H, Lee J, et al. Induction of cytochrome P450 by Rut and metabolism of Rut by cytochrome P450 [J]. Planta Med, 2004, 70(6):753.
28. Ueng Y F, Don M J, Jan W C, et al. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450 [J]. Drug Metab Dispos, 2006, 12(5):598.
29. Han E H, Kim H G, Im J H, et al. Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium[J]. Toxicology, 2009, 266:38.
30. Don M J, Lewis D F V, Wang S Y, et al. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1[J]. Bioorg Med Chem Lett, 2003, 13:2535.
31. Chatterjee P, Franklin M R. Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components [J]. Drug Metab Dispos, 2003, 31(11):1391.
32. Henderson G L, Harkey M R, Gershwin M E, et al. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity [J]. Life Sci, 1999, 65:209.
33. von Mohke L L, Weemhoff J L, Bedir E, et al. Inhibition of human cytochromes P450 by components of Ginkgo biloba [J]. J Pharm Pharmacol, 2004, 56(8):1039.
34. Chang T K, Chen J, Teng X W. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured Hepatocytes [J]. Drug Metab Dispos, 2006, 34(2):234.
35. Doehmer J, Weiss G, McGregor G P, et al. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities [J]. Toxicol In Vitro, 2011, 25(1):21.
36. Xia C H, Sun J G, Wang G J, et al. Herb-drug interactions: in vivo and in vitro effect of shenmai injection, a herbal preparation, on the metabolic activities of hepatic cytochrome P450 3A1/2, 2C6, 1A2, and 2E1 in rats[J]. Planta Med, 2010, 76(3):245.